Heart disease and stroke statistics-2010 update: a report from the American Heart Association
Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010;121:e46-215.
Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years
Adeoye O, Hornung R, Katri P, Kleindorfer D. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke 2011;42:1952-1955.
Amelioration of cerebral ischemia-reperfusion injury based on liposomal drug delivery system with asialo-erythropoietin
Ishii T, Asai T, Oyama D, et al. Amelioration of cerebral ischemia-reperfusion injury based on liposomal drug delivery system with asialo-erythropoietin. J Control Release 2012;160:81-87.
Nanoparticles accumulate in ischemic core and penumbra region even when cerebral perfusion is reduced
Ishii T, Fukuta T, Agato Y, et al. Nanoparticles accumulate in ischemic core and penumbra region even when cerebral perfusion is reduced. Biochem Biophys Res Commun 2013;430:1201-1205.
In vivo distribution of liposome-encapsulated hemoglobin determined by positron emission tomography
Urakami T, Kawaguchi AT, Akai S, et al. In vivo distribution of liposome-encapsulated hemoglobin determined by positron emission tomography. Artif Organs 2009;33:164-168.
Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion
Nagasawa H, Kogure K. Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke 1989;20:1037-1043.
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000;65:271-284.
Caspase-3 contributes to ZO-1 and CL-5 tight-junction disruption in rapid anoxic neurovascular unit damage
Zehendner CM, Librizzi L, de Curtis M, Kuhlmann CR, Luhmann HJ. Caspase-3 contributes to ZO-1 and CL-5 tight-junction disruption in rapid anoxic neurovascular unit damage. PLoS ONE 2011;6:e16760.
A single injection of liposomal asialo-erythropoietin improves motor functional deficit caused by cerebral ischemia/reperfuision
Ishii T, Asai T, Fukuta T, et al. A single injection of liposomal asialo-erythropoietin improves motor functional deficit caused by cerebral ischemia/reperfuision. Int J Pharm 2012;439:269-274.